Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson’s disease
- 31 December 2006
- journal article
- Published by Elsevier BV in Clinical Neuroscience Research
- Vol. 6 (5), 261-281
- https://doi.org/10.1016/j.cnr.2006.09.006
Abstract
No abstract availableKeywords
This publication has 253 references indexed in Scilit:
- Dopaminergic neurotoxicity by 6-OHDA and MPP+: Differential requirement for neuronal cyclooxygenase activityJournal of Neuroscience Research, 2005
- Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson diseaseHuman Genetics, 2005
- Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patientsNeurological Sciences, 2002
- Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-α, interleukin-1β, and nitric oxideDevelopmental Brain Research, 2002
- Alterations in the distribution of glutathione in the substantia nigra in Parkinson's diseaseJournal of Neural Transmission, 1997
- T-lymphocyte immuno-interferon binding in parkinsonian patientsJournal of Neural Transmission, 1997
- Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patientsNeuroscience Letters, 1994
- The biological significance of malondialdehyde determination in the assessment of tissue oxidative stressLife Sciences, 1991
- Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brainJournal of Neural Transmission, 1988
- Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patientsNeuroscience Letters, 1986